DR. JENNIFER VITTORIO, M.D.

Plain English
A liver disease specialist committee developed 41 quality measures covering the entire pre-transplant journey — from when a doctor first refers a patient through organ acceptance — to reduce variation in how transplant centers evaluate and list patients. The measures span structure, process, and outcomes, with patients rating "understanding the transplant process" as most important. This framework gives transplant programs a concrete tool for local quality improvement that goes beyond what's already tracked for regulatory reporting.

Plain English
This study tested whether a once-daily tacrolimus formulation (LCP-tacrolimus) improved medication adherence in young transplant patients aged 12 and up, who are known to struggle with daily medications. Switching to the once-daily version showed numerically better adherence by both provider assessment and a standard measurement tool, though the improvements did not reach statistical significance — likely because the group was too small. The drug was safe and effective, but did not reduce pill burden and sometimes cost more, so it may be best suited for carefully selected patients.

Plain English
Surveys of 40 pediatric and 79 adult liver transplant programs revealed a major gap: pediatric centers are far more likely to have formal transition policies, clinics, and readiness tools than adult centers, even though young patients are at high risk for rejection and graft loss during the handoff period. Both sides agreed on the key barriers — patients who disengage, missed appointments, and limited staff. The authors call for structured partnerships between pediatric and adult teams to close this gap.

Plain English
This open-label extension study followed children and new patients with progressive familial intrahepatic cholestasis treated with odevixibat, a pill that blocks bile acid recycling in the gut. Across all patient groups, the drug sustained reductions in blood bile acid levels and reduced itching over 24 weeks, with most side effects being mild. The results support odevixibat as a well-tolerated option that addresses both the biochemical and quality-of-life burden of this severe inherited liver disease.

Plain English
Researchers analyzed genetic data from 758 patients with chronic liver disease, looking for mutations in 502 genes linked to inherited liver conditions. After careful filtering, they found a definitive genetic diagnosis in 5.7% of patients — a meaningful number given that many of these conditions have specific treatment implications, including family screening and preventive care. The study shows that exome sequencing can uncover inherited causes of liver disease, but requires multiple rounds of expert review to avoid false results.

Plain English
Liver removal surgery in children carries real risks, but population-level data on complications are limited. Using a national pediatric surgical database, researchers identified which factors—including wound class and operative time—predict unplanned readmission within 30 days of hepatectomy. These benchmarks help hospitals identify high-risk patients and plan better follow-up care.

Plain English
Genetic testing is increasingly identifying Wilson disease — a copper metabolism disorder — in infants and even before birth, long before the condition causes symptoms. Because there is almost no published guidance on managing babies diagnosed this way, the authors present a case and propose a stepwise treatment algorithm based on the physiology of copper in early development. Their goal is to start a conversation among specialists and build evidence-based best practices for this emerging clinical situation.

Plain English
Children who receive livers from living donors—usually parents—have better long-term outcomes than those receiving deceased-donor organs, but living donor transplants remain rare in the U.S. This study found that living-donor recipients also showed immunological advantages, with lower rejection rates likely tied to the partial genetic match with a parent donor. The data make a strong case for expanding living donor programs for children.

Plain English
A 12-year-old boy who had received a liver transplant as an infant developed a stone in his intestine that blocked food from moving through his bowel, cutting off blood flow to that section of intestine and causing it to die. Doctors had to remove the damaged intestine and rebuild his surgical connection between the liver and intestine to fix the problem. **Why it matters:** This rare complication should be on doctors' radar when transplant patients develop fever and stomach pain, and it shows that sometimes fixing the underlying anatomy—not just treating the stone—prevents the problem from happening again.

Plain English
Anakinra, an anti-inflammatory drug used to treat certain autoimmune conditions, caused acute liver failure in a teenage boy being treated for adult-onset Still's disease. The liver failure resolved when the drug was stopped. While liver toxicity from anakinra had been reported in adults, this appears to be the first documented case of severe acute liver failure in an adolescent, underscoring the need to monitor liver function closely in any patient on this medication.